We spoke to new Sterling Energy CEO Tony Hawkins about the latest changes happening at the company. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,291.00
Bid: 2,291.00
Ask: 2,293.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.09%)
Open: 2,299.00
High: 2,330.00
Low: 2,210.00
Yest. Close: 2,417.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

DIRECTOR DEALINGS: Hikma Chair And Vice Chair Buy 20,000 Shares Each

LONDON (Alliance News) - Hikma Pharmaceuticals PLC said that both its executive chair and executive vice chair bought a substantial number of shares on Wednesday.Executive Chair Said bought

13 Mar 19 14:16

LONDON MARKET MIDDAY: Stocks Subdued, Pound Rises Ahead Of Brexit Vote

LONDON (Alliance News) - London stocks were trading broadly flat at midday on Wednesday, with the pound creeping higher ahead of this evening's vote in Westminster, when members of Parliament

13 Mar 19 11:59

WINNERS & LOSERS SUMMARY: Avast CEO Departure Overshadows Results

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------Standard

13 Mar 19 10:41

TOP NEWS: Hikma Swings To Profit After Columbus Impairment Year Before

LONDON (Alliance News) - Hikma Pharmaceuticals PLC on Wednesday said it swung to a profit from a loss in 2018 due to good demand, new product launches, and a substantial impairment the year drug a

13 Mar 19 09:00

Hikma Pharma profits jab higher

(Sharecast News) - Hikma Pharmaceuticals grew 2018 sales and profits much more than it had expected at the start of last year, but final numbers and guidance for 2019 from the speciality and generic drug maker were both a little short of upgraded market forecasts.

13 Mar 19 08:56

LONDON MARKET PRE-OPEN: Standard Life Board Shake-Up; Morrisons Payout

LONDON (Alliance News) - Stock prices in London are set to open lower on Wednesday, while the pound was steady after UK Prime Minister Theresa May's latest defeat in Parliament over her Brexit

13 Mar 19 07:50

Wednesday preview: WA votes in Parliament, Hikma Pharmaceuticals

(Sharecast News) - Investors may be facing heightened volatility on Wednesday, as financial markets digest the result of Parliament's vote on Theresa May's proposal for the UK's withdrawal agreement with the European Union.

12 Mar 19 14:55

Hikma Appoints Former Ipsen And Eisai North American Boss To Board

LONDON (Alliance News) - Hikma Pharmaceuticals PLC on Tuesday announced the former head of the US businesses of Ipsen and Eisai will be joining as a non-executive director.Cynthia Schwalm a

12 Mar 19 08:37

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 7 March Melrose IndustriesFull Year ResultsNMC HealthFull Year Year Year Year 8

6 Mar 19 15:56

Tobacco stocks rise after FDA boss Gottlieb quits

(Sharecast News) - Shares in tobacco companies rose on Wednesday after America's chief drug and tobacco regulator unexpectedly resigned overnight.

6 Mar 19 09:20

Hikma Pharmaceuticals Launches Cancer Treatment Mitomycin In US

LONDON (Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it has launched cancer treatment Mitomycin as an injection in the US.Mitomycin, administered in doses of either 20 or 40 a

29 Jan 19 12:11

Hikma launches generic Mitomycin injection in US

(Sharecast News) - Hikma Pharmaceuticals announced on Tuesday that its Hikma Pharmaceuticals USA division, formerly known as West-Ward Pharmaceuticals, has launched Mitomycin for Injection, USP' at dosages of 20mg and 40mg.

29 Jan 19 09:42

Hikma US launches generic version of Lundbeck's Onfi

(Sharecast News) - Hikma Pharmaceuticals' US subsidiary has launched a generic equivalent to Lundbeck's Onfi, which is used for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients of two years and older.

10 Dec 18 14:18

New management to reinvigorate Smith & Nephew, says Morgan Stanley

(Sharecast News) - Morgan Stanley upped its stance on Smith & Nephew to 'overweight' from 'equalweight' on Monday, lifting the target price to 1,692p from 1,457p as it argued that new management should help to reinvigorate the top line performance following years of stagnation.

10 Dec 18 13:31

Hikma Pharmaceuticals Launches Onfi Generic Clobazam In US

LONDON (Alliance News) - Hikma Pharmaceuticals PLC on Monday said its US unit has launched Clobazam oral suspension and Clobazam tablets, the generic equivalent to Onfi.Clobazam is the name

10 Dec 18 11:22

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.